Head and Neck Cancer

Title(s):
CTSU E1305. A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer

Investigator(s):
Esther Rehmus, MD

Contact Information:
McDowell Cancer Research at 330-344-6348

Title(s):
RTOG 0920. A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer

Investigator(s):
Mitchel Fromm, MD

Contact Information:
McDowell Cancer Research at 330-344-6348

Title(s):
RTOG 1016. Phase III Trial of Radiotherapy Plus Cetuximab versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer

Investigator(s):
Mitchel Fromm, MD

Contact Information:
McDowell Cancer Research at 330-344-6348

Title(s):
RTOG 1216. Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

Investigator(s):
Mitchel Fromm, MD

Contact Information:
McDowell Cancer Research at 330-344-6348

Title(s):
CTSU E2906. Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly Diagnosed Acute Myeloid Leukemia in Older Adults (Age >= 60 Years)

Investigator(s):
Esther Rehmus, MD

Contact Information:
McDowell Cancer Research at 330-344-6348